BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10260202)

  • 1. Mission, role, and functions of the P & T Committee.
    Bell JE; Evans PJ; Standish RC
    Hosp Formul; 1983 Jun; 18(6):639-40, 643-6. PubMed ID: 10260202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The goals and functions of a P & T committee.
    Sudds TW; Williams RR
    Hosp Formul; 1985 Nov; 20(11):1163-5, 1171, 1174. PubMed ID: 10274572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The JCAHO Agenda for Change: what changes in pharmacy and P & T activities do you need to prepare for in 1994?
    Doherty EC
    Hosp Formul; 1994 Jan; 29(1):54-6, 58-60, 64 passim. PubMed ID: 10131267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pharmacy and Therapeutics Committee Part 1: overview.
    Bender FH
    Hosp Formul; 1983 May; 18(5):517-8, 523-4, 533 passim. PubMed ID: 10260199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing an effective P & T Committee, Part 2.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How a longstanding P & T Committee identifies and meets current therapeutic challenges.
    Stross J; de Leon R; Volger B
    Hosp Formul; 1991 Sep; 26(9):717-22, 724. PubMed ID: 10114003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Communicating P & T guidelines: how one committee meets the challenge.
    Dreyfus R; Bender F
    Hosp Formul; 1987 Jul; 22(7):651-4, 657. PubMed ID: 10282681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW; Keith TD; Foster MT
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective decision-making in a changing healthcare environment: a P & T Committee interview.
    Zoloth A; Yon JL; Woolf R
    Hosp Formul; 1989 Feb; 24(2):85-7, 90, 93 passim. PubMed ID: 10291815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of a clinical pharmacology consult service as a formulary management tool.
    Albertson T; Musallam N; Tharratt S; Romac D; Foulke G; Mowers R; Panecek E
    Hosp Formul; 1993 Aug; 28(8):699-702, 707. PubMed ID: 10127748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organization and operation of P & T Committees in the state of Florida: a survey.
    Hatton RC; Doering PL
    Hosp Formul; 1990 Sep; 25(9):983-6, 988-9. PubMed ID: 10106259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P & T Committee roundtable discussion: Eastern region Pt. II.
    Fine DJ; Guild RT; Kleinmann K; Kupersmith J
    Hosp Formul; 1984 Jul; 19(7):561-4, 568-70. PubMed ID: 10267389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH; Szeinbach SL
    Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purchasing and inventory control--past, present, and future.
    Skolaut MW; McAllister JC
    Am J Hosp Pharm; 1984 Mar; 41(3):522-5. PubMed ID: 6702857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing an effective P&T Committee, Part I.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Jul; 20(7):827-8, 837, 841-3 passim. PubMed ID: 10271920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P & T Committee roundtable discussion: Eastern region. Part I.
    Fine DJ; Guild RT; Kleinmann K; Kupersmith J
    Hosp Formul; 1984 Jun; 19(6):469-72, 475-6. PubMed ID: 10266565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.